ALTO-100 in MDD and/or PTSD
Trial details
- Registry ID
- NCT05117632
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| ALTO-100 in MDD and/or PTSDNCT05117632 | Alto Neuroscience | Phase 2 | Completed | 2022-12-01Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |